{
    "name": "sebelipase alfa",
    "comment": "Rx",
    "other_names": [
        "Kanuma"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/kanuma-sebelipase-alfa-1000011",
    "pregnancy": {
        "common": [
            "There are no available data in pregnant women to inform any drug-associated risk",
            "Animal reproductive studies conducted with sebelipase alfa showed no evidence of embryolethality, fetotoxicity, teratogenicity, or abnormal early embryonic development at dosages up to 164 and 526 times the human dosage of 1 mg/kg every other week (based on AUC) in rats and rabbits, respectively"
        ],
        "specific": []
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Hypersensitivity reactions",
                    "description": [
                        "Hypersensitivity, including anaphylaxis, reported as early as the sixth infusion and as late as 1 yr after treatment initiation",
                        "Owing to potential for anaphylaxis, assure appropriate medical support is readily available during administration ",
                        "Management based on reaction severity and may include temporarily interrupting infusion, lowering infusion rate, and/or treatment with antihistamines, antipyretics, and/or corticosteroids ",
                        "If interrupted, may resume infusion at slower rate with increases as tolerated ",
                        "Pretreatment with antipyretics and/or antihistamines may prevent subsequent reactions in those cases where symptomatic treatment was required ",
                        "If severe hypersensitivity reaction occurs, immediately discontinue infusion and initiate appropriate medical treatment "
                    ]
                },
                {
                    "type": "Hypersensitivity to eggs or egg products",
                    "description": [
                        "Product is produced in the egg whites of genetically engineered chickens",
                        "Patients with known history of egg allergies were excluded from clinical trials",
                        "Consider risks and benefits with known systemic hypersensitivity reactions to eggs or egg products"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Diarrhea",
            "percent": "67"
        },
        {
            "name": "Vomiting",
            "percent": "67"
        },
        {
            "name": "Fever",
            "percent": "56"
        },
        {
            "name": "Rhinitis",
            "percent": "56"
        },
        {
            "name": "Anemia",
            "percent": "44"
        },
        {
            "name": "Cough",
            "percent": "33"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "33"
        },
        {
            "name": "Urticaria",
            "percent": "33"
        },
        {
            "name": "Headache",
            "percent": "28"
        },
        {
            "name": "Fever",
            "percent": "25"
        },
        {
            "name": "Oropharyngeal pain",
            "percent": "17"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "11"
        },
        {
            "name": "Asthenia",
            "percent": "8"
        },
        {
            "name": "Constipation",
            "percent": "8"
        },
        {
            "name": "Nausea",
            "percent": "8"
        }
    ]
}